Keywords: jazz, net, loss, deepens, 7m, 1st, qtr
Jazz' net loss deepens to $46.7M in 1st qtr
Article | 26 May 2008
The USA's Jazz Pharmaceuticals says that first-quarter 2008 net loss increased to $46.7 million from $19.6 million in the like, year-ago period, as ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
